Resistance to Targeted Therapies Against Adult Brain Cancers
(Sprache: Englisch)
This volume will bring together a review of research being carried out by international experts in this field, detailing treatment and research approaches in several forms of malignant brain tumors. These include glioblastoma (GBM), a highly aggressive and...
Jetzt vorbestellen
versandkostenfrei
Buch (Gebunden)
Fr. 177.00
inkl. MwSt.
- Kreditkarte, Paypal, Rechnungskauf
- 30 Tage Widerrufsrecht
Produktdetails
Produktinformationen zu „Resistance to Targeted Therapies Against Adult Brain Cancers “
Klappentext zu „Resistance to Targeted Therapies Against Adult Brain Cancers “
This volume will bring together a review of research being carried out by international experts in this field, detailing treatment and research approaches in several forms of malignant brain tumors. These include glioblastoma (GBM), a highly aggressive and fatal form of astrocytoma which accounts for 80% of newly diagnosed brain tumor patients per year, and meningioma, of which 10% are malignant and extremely resistant to targeted therapies. The volume will also include a discussion of methods to overcome blood-brain barrier exclusion for more efficient targeted drug delivery in all forms of brain cancer treatment. The volume will include information on the repurposing of drugs in an attempt to circumvent drug resistance, use of small molecule inhibitors in GBM treatment, mechanisms of secondary brain metastasis, drug resistance, and state-of-the-art imaging of targeted therapies.Inhaltsverzeichnis zu „Resistance to Targeted Therapies Against Adult Brain Cancers “
Targeted therapies in gliomas: An overview.- Targeting chemotherapy resistance in glioblastoma through modulation of ABC transporters.- Resistance of Glioblastomas to Radiation Therapy.- The blood-brain barrier in glioblastoma multiforme: Pathology and therapeutic implications.- Resistance of brain tumours to small-molecule targeted therapies: lessons from various cancer types.- Drug repurposing to circumvent chemotherapy resistance in brain tumours.- Small molecule inhibitors in glioblastoma: Key pathways and resistance mechanisms.- Imaging Targeted Therapy Response and Resistance in Glioblastoma.- Drug Resistance in Malignant Meningiomas.- Recurrence of Low-Grade Glioma - Have the Targeted Therapies Improved for Better Outcomes?.- Host-Tumor Interactions in Brain Cancer Metastasis Leading to Drug Resistance.Autoren-Porträt
Amanda Tivnan, PhD, is Senior Postdoctoral Research Fellow, Department of Physiology and Medical Physics, The Royal College of Surgeons, Dublin, Ireland.
Bibliographische Angaben
- 2016, 1st ed. 2016, XVI, 260 Seiten, 16 farbige Abbildungen, Masse: 16 x 24,1 cm, Gebunden, Englisch
- Herausgegeben: Amanda Tivnan
- Verlag: Springer, Berlin
- ISBN-10: 331946504X
- ISBN-13: 9783319465043
- Erscheinungsdatum: 16.12.2016
Sprache:
Englisch
Pressezitat
"This is a complete monograph on the molecular and cell biology of 'brain tumors' resistant mechanisms. The book discusses chemotherapy and radiotherapy of brain malignancies including gliomas, ependynomas, and meningiomas. ... I highly recommend this book as a reference and research tool for neurosurgeons, oncologists, neurologists, residents, and students." (Joseph Grenier, Amazon.de, May, 2018)
Kommentar zu "Resistance to Targeted Therapies Against Adult Brain Cancers"
0 Gebrauchte Artikel zu „Resistance to Targeted Therapies Against Adult Brain Cancers“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Resistance to Targeted Therapies Against Adult Brain Cancers".
Kommentar verfassen